Pacific Biosciences Of California | PACB - Current Liabilities

Stock Price
1.72
Daily Change
0.03 1.78%
Monthly
23.74%
Yearly
50.88%
Q2 Forecast
1.65

Pacific Biosciences Of California reported $72.83M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 6.81B 483M Dec/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Illumina USD 1.59B 377M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Quidel USD 966.1M 198.2M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Waters USD 1.24B 11.8M Dec/2025